• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsZeria Pharmaceutical
    Picture of Zeria Pharmaceutical logo

    4559 — Zeria Pharmaceutical Share News

    ¥2,0240.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeMid CapNeutral
    • Market Cap
      ¥89bn
    • Enterprise Value
      ¥98bn
    • Revenue
      ¥89bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 4559 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    4559 Dividends
    • 2016 6-month group forecast

      31/10/2016 02:00
    • Brief: Zeria Pharmaceutical gets manufacture and marketing approval for Zentacort Capsules 3mg

      28/09/2016 07:28
    • Table: Zeria Pharm -Q1 group results

      04/08/2016 08:00
    • Table: Zeria Pharm -2015/16 group results

      13/05/2016 08:00
    • Table: Zeria Pharm -2015/16 parent results

      13/05/2016 08:00
    • Table: Zeria Pharm -9-MTH group results

      04/02/2016 07:00
    • Table: Zeria Pharm -6-MTH group results

      04/11/2015 07:00
    • Table: Zeria Pharm -2015/16 group forecast

      28/10/2015 04:00
    • 2015 6-month group forecast

      28/10/2015 04:00
    • Brief: Astrazeneca sells non-US global rights for gastroenterology drug to Tillotts Pharma

      09/07/2015 07:32
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.